Rifaximin is a semi-synthetic antibiotic used to treat gastrointestinal diseases. It is used to treat travelers' diarrhea, irritable bowel syndrome with diarrhea, and hepatic encephalopathy. Rifaximin is also used to prevent recurrent episodes of hepatic encephalopathy. It is a broad-spectrum antibiotic that is effective against both Gram-positive and Gram-negative bacteria. Rifaximin is available in both oral and intravenous formulations. The oral formulation is available as tablets, capsules, and granules. The intravenous formulation is available as a solution for injection. Rifaximin is available in several countries, including the United States, Canada, and Europe. Rifaximin is a relatively new drug in the gastrointestinal drugs market. It is used to treat a variety of gastrointestinal diseases, and is becoming increasingly popular due to its effectiveness and safety profile. Some companies in the Rifaximin market include Salix Pharmaceuticals, Inc., Actavis, Inc., and Lupin Pharmaceuticals, Inc. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
